secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001093557-25-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom reports preliminary Q4 revenue $1.113B (+8% YoY); guides 2025 revenue $4.60B (+14%)
--------------------------------------------------------------------------------

- Q4 2024 preliminary revenue at least $1.113B, up 8% YoY; US revenue $803M (+4%), international $310M (+17%).
- FY2024 total preliminary revenue ~$4.032B, up 11% YoY.
- Updated 2024 non-GAAP gross margin guidance to 62% and operating margin to 19%; Q4 margin hit by non-cash charge.
- 2025 revenue guidance $4.60B (+14%); non-GAAP gross margin 64-65%, operating margin ~21%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000004/0001093557-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000004/dxcm-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001093557-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer